Design and Evaluation of Lovastatin Solid Dispersions Incorporated Trilayer Matrix Tablets
Abstract
The current work is aimed to design, prepare and evaluate the trilayer matrix tablets incorporated with lovastatin solid dispersion (SD) for extend drug release. The lovastatin SD prepared by using solvent evaporation technique with varying amounts of polymers (GMS II, Soluplus, Kolliphor ELP, PEG 2000 and Urea) for enhancing the drug solubility. All the formulations examined for physicochemical parameters are within the permissible limits. The optimized SD formulation was incorporated into trilayer matrix tablets which were prepared using different polymers (HPMC 15M & K100M, Chitosan, xanthan gum) by direct compression method for sustaining the drug release. The drug dissolution of optimized lovastatin SD formulation SD15 (drug, soluplus and SLN) was 99.88±5.32% within 60 min which is higher than pure drug 47.33±2.25% and other formulations. The FT-IR, XRD and SEM data assure the compatibility of drug and excipients and amorphous nature of lovastatin. The solid dispersions were further incorporated in to trilayer matrix tablets with active layer and barrier layers. Eight formulations of lovastatin trilayer matrix tablets (AF9-HF9) designed and checked for pre compression parameters. Formulation GF9 demonstrated highest drug release of 99.41±5.28% for 24 hours sustainably over an extended period of time and excellent flow properties. The release order kinetics data indicate the zero order release with highest R2 of 0.9957 for GF9, superior than market extended release formulation (R2=0.9934). All the formulations showed best fit to Higuchi model and Korsmeyer-Peppa’s model indicating diffusion and non-Fickian diffusion process of drug release. GF90 was found to be stable for 180 days at accelerated conditions. Hence the solubility, dissolution rate of lovastatin was enhanced by SD technique further incorporated in to trilayer matrix tablets for sustainable extended drug release upto 24 h.
Keywords:
Lovastatin, HMG-CoA reductase inhibitors, Kolliphor ELP, Solid dispersions, Trilayer matrix tabletsDOI
https://doi.org/10.25004/IJPSDR.2020.120409References
Mallick Sahu A, Paul K. Dissolution behaviour of Nalidixic acid solid dispersions using water soluble solid dispersions carriers. Acta Pol Pharm Drug Res. 2004; 60 (1): 21-30.
Sammour OA, Zidan AS, Hammad MA, Megrab NA. Formulation and Optimization of Mouth Dissolve Tablets Containing Rofecoxib Solid Dispersion. AAPS Pharm Sci Tech. 2006; 7(2): 162-69.
Shin SC, Kim J. Physicochemical Characterization of Solid Dispersion of Furosemide with TPGS. Int J Pharm. 2003; 251:79-84.
Craig DQM. The mechanisms of Drug Release from Solid Dispersions in Water-Soluble Polymers. Int J Pharm. 2002; 231:131–144.
De Waard H, Hinrichs WLJ, Frijlink HW. A novel bottom-up process to produce drug nano crystals controlled crystallization during freeze-drying. J Con Rel. 2008; 128:179–183.
Higuchi T, Connoras K. Phase-solubility techniques. Adv Anal ChemInstrum. 1965; 4:117-212.
Swathi P, Anand YK. Formulation and Evaluation of Ritonavir Solid Dispersions. Int J Res Dev Pharm L Sci. 2017; 6(2):2522-2529.
Mohammadi H, Hemanath Kumar V. Formulation and Evaluation of Solid Dispersion Incorporated Fast Disintegrating Tablets of Tenoxicam Using Design of Experiment. Int J Pharm Sci Drug Res. 2019; 11(1):35-44.
Vanshiv SD, Rao MRP, Sonar GS. Physicochemical characterization and in vitro dissolution of Domperidone by solid dispersion technique. Ind J Pharm Edu Res. 2009; 43(1):86-90.
SubhashKatore, Bidkar SJ, Dama GY. Formulation& Evaluation of Ciprofloxacin Solid Dispersion Controlled Release Floating Capsules for Solubility Improvement. Indian J Pharm Biol Res. 2017; 5(3):7-16.
Batra V, Shirolkar VS, Mahaparale PR. Solubility and dissolution enhancement of glipizide by solid dispersion technique. Ind J Pharm Edu Res. 2008; 42(4):373-378.
Yadav B, Tanwar YS .Development, Characterization and In Vitro Evaluation of Flurbiprofen Solid Dispersions using Polyethylene Glycols as Carrier. J App Pharm Sci. 2016; 6(04): 060-066.
Mohammadi Ghobad, Barzegar-Jalali Azim, Khosro Adibkia. Development and Characterization of Solid Dispersion for Dissolution Improvement of Furosemide by Co grinding Method. Adv Pharm Bull. 2014; 4(4): 391-399.
Soliman MS, Khan MA. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire44/14 and Labrasol. Pharmazie. 2005; 60(4): 288-293.
Etman MA, Nada AH. Hydrotropic and cosolvent solubilisation of indomethacin. Acta Pharm. 1999; 49:291–298.
Reddy G, Vidyadhara S, Babu J, Rlc Sasidhar, Ramu A. Formulation and Evaluation of Lovastatin Solid Dispersions with Pregelatinised Starch as Newer Super disintegrant. J of Pharm Res 2012; 11:38.
Afroze A, Sabya SD, Afzal H, Abdul F. Formulation and Evaluation of Solid Dispersion and Inclusion Complex of Poorly Aqueous Soluble Diacerein. JOJ Material Sci. 2018; 5(1): 555-651.
Saravanan M, Natraj KS, Ganesh KS. The effect of tablet formulation and hardness on in vitro release of cephalexin from Eudragit L100 based extended release tablets. Biol Pharm Bull. 2002; 25: 4541-5
Afrasim M, Shivakua HG. Formulation of Sustained-release diltiazem matrix tablets using hydrophilic gum blends. Trop J of Pharm Res. 2010; 9: 283-291.
Thenge R, Mahajan SS, Mahajan NM, Adhao V, Ajmire PV. Formulation and Evaluation of Buccoadhesive Drug Delivery System for Lovastatin. JDDT. 2019.
Anton S, Muthu AK, Wagh BP, Manavalan R. Formulation development and evaluation of ondansetron hydrochloride sustained release matrix tablets. J Pharm Sci& Res. 2009; 1: 48-54.
Saravanan M, Natraj KS, Ganesh KS. Hydroxypropyl methyl cellulose based cephalexin extended release tablets: Influence of tablet formulation, hardness and storage on in vivo release kinetics. Chem Pharm Bull. 2003; 51: 978-83.
Bhupendra G,Prajapati, Patel KR. Design and in vitro evaluation of novel nicorandil sustained release matrix tablets based on combination of hydrophilic and hydrophobic matrix system. Int J of Pharm Sci Rev and Res 2010;1(1):33-38.
Reddy KR, Mutalik S, Reddy S. Once daily sustained release matrix tablets of nicorandrail, formulation and in vitro evaluation. AAPS Pharm Sci Tech. 2003; 4: 61.
Siepmann J, Kranz H, Bodmeier R, Peppas NA. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm Res. 1999; 16: 1748-1756.
Ganesh R. Suresh K, Jawahar, Senthil V, Nagasamy D. Preparation and evaluation of sustained release matrix tablet of diclofenac sodium using natural polymer. J of Pharm Sci & Res 2010; 2: 360-368.
Published
Abstract Display: 422 
PDF Downloads: 490 
